Sagent Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT PHARMS, and what generic and branded alternatives to SAGENT PHARMS drugs are available?
SAGENT PHARMS has seventy-eight approved drugs.
There is one tentative approval on SAGENT PHARMS drugs.
Drugs and US Patents for Sagent Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sagent Pharms Inc | CYCLOPHOSPHAMIDE | cyclophosphamide | INJECTABLE;INJECTION | 214529-001 | Jul 17, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sagent Pharms Inc | SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 207426-001 | Dec 8, 2016 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sagent Pharms Inc | ESMOLOL HYDROCHLORIDE | esmolol hydrochloride | INJECTABLE;INJECTION | 207107-001 | Jun 8, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sagent Pharms Inc | LINEZOLID | linezolid | SOLUTION;INTRAVENOUS | 204696-001 | Mar 2, 2017 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.